Endpoint definition
↥| Name | L12_LINEARSCLERODERMA |
|---|---|
| Long name | Linear scleroderma |
| Hospital Discharge registry | ICD-10: L941 |
| Cause of Death registry | ICD-10: L941 |
| Level in the ICD-hierarchy | 4 |
| First defined in version | DF2 |
| Latin name | Scleroderma lineare |
Linear scleroderma
scleroderma: Scleroderma is a rare autoimmune connective tissue disorder characterized by abnormal hardening of the skin and, sometimes, other organs. It is classified into two main forms: localized scleroderma and systemic sclerosis (SSc), the latter comprising three subsets; diffuse cutaneous SSc (dcSSc), limited cutaneous SSc (lcSSc) and limited SSc (lSSc) (see these terms).
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 15 | 9 | 6 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
| Mean age at first event (years) | 40.20 | 37.24 | 44.63 |
| Case fatality at 5-years (%) | 0.00 | 0.00 | 0.00 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 2.0 | 1.0 | 3.0 |
| Recurrence at 6 months (%) | 46.67 | 33.33 | 66.67 |
Survival analyses between endpoints
↥Plot
before Linear scleroderma
after Linear scleroderma
Loading survival analyses plot…
Table
Loading survival analyses table…